CAS: 18856-63-8; 4-Ethylphenyl Isothiocyanate

上下游产品

CAS号463-71-8 硫光气 | CAS号589-16-2 4-乙基苯胺 | CAS号89573-81-9 1,3-bis(4-ethyl... | CAS号95167-89-8 N-(4-ethyl-phen... | CAS号93693-01-7 4-4 -乙苯基-3-氨基硫脲 | CAS号22265-78-7 1-(对乙基苯基)-2-硫脲

📜1,3-双(4-乙基苯基)硫脲置于盐酸,磷酸,Phosphorus Pentoxide体系中,化学反应生成4-乙基异硫氰酸苯酯
参考文献:Mainzer,Chemische Berichte,1883,Vol. 16,P. 2017
标题:Mainzer,Chemische Berichte,1883,Vol. 16,P. 2017

专利信息

专利号:US-8062756-B2
优先权日:2005-08-26
标题:Stepwise growth of oligomeric redox-active molecules on a surface without the use of protecting groups
发明人：BOCIAN DAVID F; LINDSEY JONATHAN S; JIAO JIEYING
权利人:BOCIAN DAVID F; LINDSEY JONATHAN S; JIAO JIEYING; REGENTS OFT THE UNIVERSITY OF CALIFORNIA; UNIV NORTH CAROLINA STATE
摘要:This invention provides a procedure for growing oligomers via a stepwise process. The oligomers can include porphyrins, which have been previously shown to be attractive candidates for molecular-based information storage. The stepwise synthesis procedure requires no protecting groups, thus eliminating protection/deprotection reactions that add complexity to the process.

专利号:US-9028800-B2
优先权日:2007-01-11
标 题 :Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
发明人：D SOUZA CHRISTOPHER A; MCBRIDE WILLIAM J; GOLDENBERG DAVID M
权利人:IMMUNOMEDICS INC
摘要:The present application discloses compositions and methods of synthesis and use of 18 F or 19 F-labeled molecules of use in PET, SPECT and/or MR imaging. Preferably, the 18 F or 19 F is conjugated to a targeting molecule by formation of a complex with a group IIIA metal and binding of the complex to a bifunctional chelating agent, which may be directly or indirectly attached to the targeting molecule. In other embodiments, the 18 F or 19 F labeled moiety may comprise a targetable construct used in combination with a bispecific antibody to target a disease-associated antigen. The disclosed methods and compositions allow the simple and reproducible labeling of molecules at very high efficiency and specific activity in 30 minutes or less. In preferred embodiments, the labeled molecule may be used for imaging in a subject without purification after labeling.